Home > Riviste > Minerva Endocrinologica > Fascicoli precedenti > Articles online first > Minerva Endocrinologica 2020 Feb 18

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi PROMO
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

 

Minerva Endocrinologica 2020 Feb 18

DOI: 10.23736/S0391-1977.20.03122-3

Copyright © 2020 EDIZIONI MINERVA MEDICA

lingua: Inglese

Sitagliptin relieves diabetic nephropathy fibrosis via the MAPK/ERK signaling pathway

Shufeng CHENG 1, Liang LI 2, Chunquan SONG 3, Huijing JIN 4, Shouguo MA 5, Ping KANG 6

1 Department of Nephrology, the People’s Hospital of Zhangqiu Area, Jinan, China; 2 Department of Pharmacy, Yidu Central Hospital of Weifang, Weifang, China; 3 Department of Pharmacy, Qingdao Central Hospital, Qingdao, China; 4 Ward Department, the People’s Hospital of Zhangqiu Area, Jinan, China; 5 Department of Burn and Plastic Surgery, the People’s Hospital of Zhangqiu Area, Jinan, China; 6 Department of Rehabilitation, the People’s Hospital of Zhangqiu Area, Jinan, China


PDF


inizio pagina